8-K: Nukkleus Subsidiary SC II Closes $172.5M IPO

Sentiment:

Initial Public Offering Closing


Nukkleus Inc. announced the successful closing of the initial public offering for its corporate-sponsored SPAC, SC II Acquisition Corp., raising $172.5 million.

Capital raiseSC II Acquisition Corp. completed its initial public offering, raising gross proceeds of approximately $172.5 million.The offering involved the sale of 17,250,000 units at $10.00 per unit, including the full exercise of the underwriters' over-allotment option.SC Capital II Sponsor LLC, an indirect subsidiary of Nukkleus, acquired 255,000 Sponsor Units at $10.00 per unit in a private placement.

Summary

  • Nukkleus Inc. announced the closing of the initial public offering (IPO) of SC II Acquisition Corp. (SC II), a newly formed special purpose acquisition company and indirect subsidiary.
  • SC II raised gross proceeds of approximately $172.5 million from the sale of 17,250,000 units.
  • The units were sold at an offering price of $10.00 per unit.
  • Each unit consists of one Class A ordinary share and one right to receive one-fifth (1/5) of a Class A ordinary share upon the consummation of an initial business combination.
  • The underwriters fully exercised their option to purchase up to an additional 2,250,000 units to cover over-allotments.
  • SC Capital II Sponsor LLC, a Delaware limited liability company and indirect subsidiary of Nukkleus (in which Nukkleus holds a majority interest), is acting as the sponsor of SC II.
  • Simultaneously with the IPO closing, the Sponsor acquired 255,000 Sponsor Units at a price of $10.00 per unit through a private placement.

Sentiment

Score: 8

Explanation: The successful closing of SC II's IPO, including the full exercise of the over-allotment option, indicates strong market confidence and provides substantial capital for future strategic acquisitions within Nukkleus's aerospace and defense focus. This event strengthens Nukkleus's strategic position.

Positives

  • Successful closing of SC II's IPO, generating significant gross proceeds of $172.5 million.
  • Full exercise of the underwriters' over-allotment option, indicating strong market demand for the offering.
  • Nukkleus Inc. holds a majority interest in the sponsor of SC II, providing strategic control and potential future benefits from SC II's activities.
  • The IPO provides SC II with substantial capital to pursue its initial business combination, aligning with Nukkleus's strategic focus on the aerospace and defense industry.

Risks

  • Forward-looking statements, such as the prospects of completing a future business combination, are subject to risks and uncertainties that could cause actual results to differ materially.
  • Readers are cautioned not to place undue reliance on forward-looking statements.

Future Outlook

SC II Acquisition Corp. will now focus on identifying and consummating an initial business combination. The prospects of completing such a combination are considered forward-looking statements subject to various risks and uncertainties.

Management Comments

  • Nukkleus Inc. is a strategic acquirer and developer of high-potential businesses in the aerospace and defense (A&D) industry.
  • Menachem Shalom, Chief Executive Officer of Nukkleus, also serves as the Chief Executive Officer of SC II.

Industry Context

Nukkleus Inc. strategically focuses on acquiring and scaling mission-critical suppliers within the defense, aerospace, and advanced manufacturing sectors, targeting Tier 2 and Tier 3 companies that are vital to national security infrastructure. The successful IPO of SC II, a corporate-sponsored SPAC, provides a dedicated vehicle to pursue these strategic acquisitions, aligning with broader industry trends of consolidation and modernization to support resilient supply chains and dual-use innovation.

Comparison to Industry Standards

  • The IPO unit price of $10.00 is a standard offering price for special purpose acquisition companies (SPACs) in the market.
  • The unit structure, consisting of one Class A ordinary share and one-fifth of a Class A ordinary share right upon business combination, is a common and widely accepted composition for SPAC units.
  • The full exercise of the underwriters' over-allotment option suggests strong investor confidence and market reception, comparable to successful SPAC IPOs in favorable market conditions.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive Officer of SC II Acquisition Corp.NAMenachem Shalom2025-11-28Appointment as CEO of the newly formed special purpose acquisition company, while also serving as CEO of Nukkleus Inc.

Related Party Transactions

  • SC Capital II Sponsor LLC, an indirect subsidiary of Nukkleus Inc. (in which Nukkleus holds a majority interest), acquired 255,000 Sponsor Units from SC II Acquisition Corp. at a price of $10.00 per unit pursuant to a private placement agreement.

Stakeholder Impact

  • Shareholders of Nukkleus Inc. (NUKK) may benefit from potential future value creation through SC II's successful business combination and Nukkleus's majority interest in the sponsor.
  • Investors in SC II Acquisition Corp. (SCIIU) now have an investment vehicle focused on strategic acquisitions within the aerospace and defense sectors.
  • Management, particularly Menachem Shalom, will have increased responsibilities due to his dual role as CEO of both Nukkleus and SC II, ensuring strategic alignment.

Next Steps

  • SC II Acquisition Corp. will now seek to identify and consummate an initial business combination.

Key Dates

DateDescription
2025-11-25Sponsor Private Placement Units Purchase Agreement dated between SC II and the Sponsor.
2025-11-25Registration statement relating to the SC II initial public offering became effective.
2025-11-28Date of earliest event reported in the Form 8-K.
2025-11-28Closing of SC II's initial public offering.
2025-11-28Nukkleus Inc. issued a press release announcing the closing of SC II's IPO.

Recommendation

buy

The successful IPO of SC II, a corporate-sponsored SPAC where Nukkleus holds a majority interest in the sponsor, provides a new avenue for growth and capital deployment within Nukkleus's strategic aerospace and defense focus. The full exercise of the over-allotment option signals strong market demand and confidence. This event strengthens Nukkleus's position and provides a vehicle for future value-accretive acquisitions, making it an attractive prospect for investors.

Keywords

SPAC, IPO, Nukkleus, SC II Acquisition Corp, aerospace, defense, A&D, special purpose acquisition company, Nasdaq, capital raise

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.